Gerald Clarke | 10/18/2013
Ahead of the Cell Based Assays Conference in December, Pharma IQ spoke with Jorrit Hornberg about the advances in vitro and in silico predictive toxicology and what this means for in vivo assays. He also spoke about the challenges in incorporating predictive toxicology into drug development.
To continue reading this story Click Here
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
DigIT Pharma & Health 2026
September 9 - 11, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More